FUNCTIONALITY ADVANCEMENT OF POORLY SOLUBLE BIOVARIABLE ANTI HYPERTENSIVE DRUG BY SOPHISTICATED SD-FBP TECHNOLOGY AS PER ENHANCED QbD

Abstract

Lacidipine (LCDP) is a dihydropyridine derivative categorized as an Anti-hypertensive Ca+2 channel blocker belonging to BCS class IV drug with low solubility and low permeability which presents a challenge to the formulation scientists. The development of a solid dispersion by solvent evaporation is a practically viable method to enhance dissolution of LCDP from oral dosage form. Solvent evaporation by Fluidized Bed Process (FBP) was the method of choice for SD as it improves wettability with simultaneous increase in porosity of granules resulting enhanced surface area producing higher dissolution rate and bioavailability of poorly water-soluble drug. Thus, the main object of the present invention is to provide stable pharmaceutical dosage form of LCDP with desired dissolution rate i.e. at least 80% drug release within 45 minutes, without use of disintegrant(s) and/or surfactant(s) or without micronization of the active ingredient per se. One more object of this invention is to provide a sophisticated robust process for the preparation of said pharmaceutical dosage form by Quality by Design (QbD) concept focusing on thorough understanding of the product and process by which it is developed and manufactured along with a knowledge of the risks involved in manufacturing by IRMA & FMEA study of the product with process and how best to mitigate those risks by developing design space with DoE & MVDA with outlined control strategy.

Authors and Affiliations

Amit Mukharya| Formulation Development (F&D) Department, Regulated Market, CADILA Pharmaceuticals Limited, 1389, Trasad Road, Dholka, Ahmedabad, Pin: 387 810, Gujarat, India, ShivangChaudhary| Formulation Development (F&D) Department, Regulated Market, CADILA Pharmaceuticals Limited, 1389, Trasad Road, Dholka, Ahmedabad, Pin: 387 810, Gujarat, India, NiyazMansuri| Formulation Development (F&D) Department, Regulated Market, CADILA Pharmaceuticals Limited, 1389, Trasad Road, Dholka, Ahmedabad, Pin: 387 810, Gujarat, India, Arun Kumar Misra| Formulation Development (F&D) Department, Regulated Market, CADILA Pharmaceuticals Limited, 1389, Trasad Road, Dholka, Ahmedabad, Pin: 387 810, Gujarat, India

Keywords

Related Articles

Anti-tumor activity of ethanolic extract of Crataeva magnaLour. (DC) against Dalton’s ascites lymphoma cell lines in mice

In recent years, the use of traditional medicine information in cancer research received considerable interest. Ethanolic Extract of Crataeva magnaLour. DC (EECM) has been used in traditional and folklore medicine for...

Development and in-vitro evaluation of Furosemide Solid Dispersion using different Water Soluble Carriers

Objective: The objective of the present investigation was to improve solubility and dissolution characteristics of Furosemide, which might offer improved bioavailability. The bioavailability of the drug when taken oral...

THE COST OF TREATMENT SERVICES IN SALMAN FARSI HOSPITAL OF BUSHEHR

This study aimed to ma te the cost of treatment services in Salman Farsi Hospital of Bushehr. In this study, activity-based cost calculation method was used to calculate the costs. The results showed that internal inten...

Preparation and evaluation of Maltodextrin based Proniosomes containing Capecitabine

Maltodextrin based capecitabine proniosomes were fabricated by conventional slurry method with different surfactant: cholesterol molar ratio keeping constant capecitabine and dicetyl phosphate concentration. The fabric...

ISOLATION, PURIFICATION AND CHARACTERIZATION OF ALKALI AND THERMO STABLE XYLANASE FROM BACILLUS SP. KS09

Nine bacterial strains were isolated using xylan rich media. The bacterial strain KS09 was selected on the basis of qualitative and quantitative test. It was identified as Bacillus sp. via physiological, morphological a...

Download PDF file
  • EP ID EP15982
  • DOI -
  • Views 395
  • Downloads 33

How To Cite

Amit Mukharya, ShivangChaudhary, NiyazMansuri, Arun Kumar Misra (2012). FUNCTIONALITY ADVANCEMENT OF POORLY SOLUBLE BIOVARIABLE ANTI HYPERTENSIVE DRUG BY SOPHISTICATED SD-FBP TECHNOLOGY AS PER ENHANCED QbD. International Journal of Research and Development in Pharmacy & Life Sciences (IJRDPL), 1(2), 72-89. https://europub.co.uk/articles/-A-15982